A Study to Evaluate the Safety of Raptiva in Adults With Plaque Psoriasis Previously Enrolled in Study ACD2600g

Study of the Drug Efalizumab (Raptiva), for Adult Patients With Moderate to Severe Plaque Psoriasis

NCT00115076 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Effects of Efalizumab on Immune Responses in Subjects With Moderate Plaque Psoriasis

NCT00382512 ·Status: COMPLETED ·Phase: PHASE1

Evaluate Whether Combination Therapy With Methotrexate and Raptiva in Psoriasis Patients is Safe and Increases Efficacy

NCT00368654 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Safety and Efficacy Study to Evaluate Efalizumab in Combination With UVB for Moderate to Severe Psoriasis

NCT00302445 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE)

NCT00096928 ·Status: COMPLETED

A Study to Evaluate Efalizumab in Adults With Plaque Psoriasis, Including Those Who Are Receiving Concomitant Antipsoriatic Therapies

NCT00338143 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Moderate to Severe Plaque Psoriasis With Involvement of the Scalp

NCT00669214 ·Status: COMPLETED ·Phase: PHASE4

Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)

NCT00602823 ·Status: COMPLETED

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

NCT00312026 ·Status: COMPLETED ·Phase: PHASE4

A Study of LY3361237 in Participants With Psoriasis

NCT04975295 ·Status: COMPLETED ·Phase: PHASE1

RESTORE: Raptiva® (Efalizumab) Evaluation of Safety and Treatment Optimization

NCT00402818 ·Status: TERMINATED

ChangE From Any Systemic psoriasiS therapY to Raptiva

NCT00697593 ·Status: TERMINATED ·Phase: PHASE4

TRUST Study: Raptiva ® in Hand & Foot Psoriasis

NCT00739882 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis

NCT01384630 ·Status: COMPLETED ·Phase: PHASE2

An Observational Study of the Use and Safety of Raptiva During Pregnancy (FOLLOW)

NCT00097240 ·Status: COMPLETED

CLEAR Study: Clinical Experience Acquired With Raptiva Study

NCT00256139 ·Status: COMPLETED ·Phase: PHASE3

ACT-128800 in Patients With Moderate to Severe Chronic Plaque Psoriasis

NCT01208090 ·Status: COMPLETED ·Phase: PHASE2

Efficacy and Safety of ABT-874 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

NCT00292396 ·Status: COMPLETED ·Phase: PHASE2

ACT-128800 in Psoriasis

NCT00852670 ·Status: COMPLETED ·Phase: PHASE2

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis

NCT03337022 ·Status: COMPLETED ·Phase: PHASE1

Efalizumab for Treatment of Patients With Moderate to Severe Psoriasis

NCT00442650 ·Status: COMPLETED ·Phase: PHASE3

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

NCT01543204 ·Status: TERMINATED ·Phase: PHASE4

Efficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 Year

NCT01365455 ·Status: COMPLETED ·Phase: PHASE3

Study to Investigate the Safety, Tolerability, Absorption, Distribution, Metabolism, and Elimination of RWJ-445380 Administered to Patients With Plaque Psoriasis

NCT00396422 ·Status: COMPLETED ·Phase: PHASE2